Market Risers: Antofagasta plc, AstraZeneca plc, Aviva plc, Berkeley Group Holdings PLC

Antofagasta Plc

The trading price for Antofagasta plc with ticker code: LON:ANTO has stepped up 2.22% or 20.8 points during today’s session. Investors have remained optimistic during the session. The period high has peaked at 959.6 and a low of 937.2. The number of shares traded by this point in time totalled 2,673,583 whilst the average number of shares exchanged is 3,902,041. The 52 week high for the share price is 1171.5 some 233.5 points in difference on the previous days close and a 52 week low being 11.12 a difference of some 926.88 points. Antofagasta plc now has a 20 simple moving average of 992.11 and the 50 day moving average now at 1043.51. The market capitalisation is now £9,518.27m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Antofagasta plc being recorded at Tuesday, July 17, 2018 at 4:35:09 PM GMT with the stock price trading at 958.8 GBX.

 

 

Shares in AstraZeneca plc with ticker code: LON:AZN has risen 1.54% or 84 points during the course of today’s session. Investors have remained optimistic throughout the trading session. The high for the period has peaked at 5559 dropping as low as 5449. The total volume of shares traded by this point was 1,942,993 with the daily average traded share volume around 2,084,739. The 52 week high for the share price is 5559 some 92 points difference from the previous days close and the 52 week low at 4260 a difference of some 1207 points. AstraZeneca plc has a 20 day moving average of 5311.6 and now a 50 day moving average of 5364.35. The current market cap is £70,757.97m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, July 17, 2018 at 4:39:42 PM GMT with the stock price trading at 5551 GBX.

 

 

The stock price for Aviva plc EPIC code: LON:AV has moved up 1.04% or 5.1 points during today’s session. Investors have stayed positive during the trading session. The period high has peaked at 495.6 dropping as low as 489.6. Volume total for shares traded at this point reached 11,306,391 whilst the daily average number of shares exchanged is just 13,923,857. The 52 week high for the share price is 554.6 equating to 65.2 points difference from the previous days close and putting the 52 week low at 482.2 a difference of some 7.19 points. Aviva plc now has a 20 SMA at 504.31 and now its 50 day moving average of 520.28. This puts the market cap at £19,605.20m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Aviva plc being recorded at Tuesday, July 17, 2018 at 4:35:10 PM GMT with the stock price trading at 494.5 GBX.

 

 

The share price for Berkeley Group Holdings PLC EPIC code: LON:BKG has risen 2.08% or 74.91 points throughout today’s trading session. Buyers have held a positive outlook throughout the session. Range high for the period is 3687 and hitting a low of 3590. The total volume of shares exchanged through this period comes to 780,119 while the daily average number of shares exchanged is 902,210. The 52 week high price for the shares is 4338 which comes in at 744 points difference from the previous close and the 52 week low at 3308 which is a difference of 286 points. Berkeley Group Holdings PLC has a 20 day moving average of 3766.5 and also a 50 day moving average now of 4049.59. This puts the market capitalisation now at £4,954.22m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Berkeley Group Holdings PLC being recorded at Tuesday, July 17, 2018 at 4:43:42 PM GMT with the stock price trading at 3668.91 GBX.

Share on:
Find more news, interviews, share price & company profile here for:
    AstraZeneca and Daiichi Sankyo's Datroway gains FDA approval, offering a new treatment option for specific metastatic breast cancer cases.
    Antofagasta Plc reports a robust Q4 2024 with a 12% increase in copper production. CEO Iván Arriagada highlights strong cost performance.
    Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders.
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.

      Search

      Search